Does RUXOLITINIB Cause Transplant dysfunction? 23 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Transplant dysfunction have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.0% of all adverse event reports for RUXOLITINIB.
23
Reports of Transplant dysfunction with RUXOLITINIB
0.0%
of all RUXOLITINIB reports
1
Deaths
3
Hospitalizations
How Dangerous Is Transplant dysfunction From RUXOLITINIB?
Of the 23 reports, 1 (4.3%) resulted in death, 3 (13.0%) required hospitalization, and 2 (8.7%) were considered life-threatening.
Is Transplant dysfunction Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 23 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Transplant dysfunction?
TACROLIMUS (944)
MYCOPHENOLATE MOFETIL (780)
CYCLOSPORINE (610)
SIROLIMUS (468)
ETANERCEPT (449)
DACLIZUMAB (421)
INFLIXIMAB (405)
PREDNISONE (240)
TACROLIMUS\TACROLIMUS ANHYDROUS (198)
THYMOCYTE IMMUNE GLOBULIN NOS (190)
Which RUXOLITINIB Alternatives Have Lower Transplant dysfunction Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE